KATELYN BAKER: Open Payments
NPI 1821542564 · EASTON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,375 in 69 payments from 13 companies in 2025. Trend: 2023 $1,797 · 2024 $1,861 · 2025 $1,375
Food & beverage: $1,221Education: $154
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $293 |
| ABBVIE INC. | 10 | $159 |
| GENZYME CORPORATION | 9 | $157 |
| Regeneron Healthcare Solutions, Inc. | 9 | $139 |
| PFIZER INC. | 7 | $137 |
| Novartis Pharmaceuticals Corporation | 4 | $101 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| Lilly USA, LLC | 4 | $99 |
| Amgen Inc. | 5 | $92 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $52 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, CIBINQO, COSENTYX, OTEZLA, TALTZ, EBGLYSS.
Industry payments across MD — which companies pay providers there.
